Innospec Inc. (IOSP) Income Statement

The quarterly series shows volatile top-line growth rather than a clean trend, with the most recent quarter at 7.2% growth following a 2.8% Q1 print. This pattern suggests recovery from the earlier contraction phase may be uneven and cyclically influenced, and investors should monitor whether the 2026Q2 peak of $491.4M is repeatable. Without segment-level volume and price disaggregation in the supplied data, it is unclear how much of the growth reflects pricing versus underlying demand.

A gross margin band of under three percentage points suggests the specialty formulation mix is buffering raw material volatility, though the pullback from 29.2% in 2024Q2 toward the mid-to-high 27% range may reflect price-cost lag. Relative to the peer set, where Balchem and Quaker Houghton report 35.7% and 36.0%, IOSP's gross margin appears structurally lower, which may limit its ability to absorb sustained feedstock inflation without operating margin compression.

Operating income has not scaled consistently with gross profit, as seen in 2026Q1 where gross profit of $123.5M translated to only $31.8M of operating income, implying heavy SG&A load of $78.5M. The stronger 2026Q3 result, with $71.7M SG&A against $129.1M gross profit, indicates better overhead absorption, though sustained leverage would require SG&A to grow more slowly than revenue over multiple periods.